Savara Inc. ( SVRA) - Key Metrics
SVRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.16 | -$0.12 | -$0.12 |
| 2026Q1 | $0 | -$0.15 | -$0.13 | -$0.13 |
| 2025Q4 | $0 | -$0.14 | -$0.11 | -$0.11 |
| 2025Q3 | $0 | -$0.14 | -$0.10 | -$0.10 |
| 2025Q2 | $0 | -$0.14 | -$0.12 | -$0.12 |
SVRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.63 |
| 2026Q1 | 0% | -9.10 |
| 2025Q4 | 0% | -11.60 |
| 2025Q3 | 0% | -6.37 |
| 2025Q2 | 0% | -4.07 |
SVRA
Price: $5.38
52 week price:
Earnings Per Share: -0.54 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 765007
Ebitda: -6.6 millionMarket Capitalization: 1.1 billion